Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study.

被引：0
|
作者：
Wu, Fang [1 ]
Wu, Sixuan [1 ]
Hu, Chunhong [1 ]
机构：
[1] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e20640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20640
引用
收藏
页数：1
相关论文
共 50 条
  • [41] EGFR-TKIs combined with chemotherapy versus EGFR-TKIs single agent as first-line treatment for molecularly selected patients with non-small cell lung cancer
    Zhixin Sheng
    Yanxia Zhang
    Medical Oncology, 2015, 32
  • [42] Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
    Onn, Amir
    Gottfried, Teodor
    Stemmer, Amos
    Appel, Sarit
    Lawrence, Yaacov R.
    Urban, Damien
    Beller, Tamar
    Daher, Sameh
    Bar, Jair
    CANCERS, 2021, 13 (11)
  • [43] Overview of the multifaceted resistances toward EGFR-TKIs and new chemotherapeutic strategies in non-small cell lung cancer
    Keflee, Rashidi Dzul
    Leong, Kok Hoong
    Ogawa, Satoshi
    Bignon, Jerome
    Chan, Mun Chiang
    Kong, Kin Weng
    BIOCHEMICAL PHARMACOLOGY, 2022, 205
  • [44] Enhancement of chemosensitivity by WEE1 inhibition in EGFR-TKIs resistant non-small cell lung cancer
    Liu, Di
    Cao, Ziyang
    Xu, Wen
    Lin, Ge
    Zhou, Xiao
    Ding, Xi
    Wang, Na
    Wu, Chunyan
    Su, Bo
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [45] ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
    Sun, Dantong
    Teng, Fei
    Xing, Puyuan
    Li, Junling
    MOLECULAR MEDICINE, 2021, 27 (01)
  • [46] Relative Abundance of EGFR Mutations Predict Tumor Metastasis and EGFR-TKIs Prognosis in Patients with Non-Small Cell Lung Cancer
    Wang, Qiming
    Wang, Hongyan
    Tang, Hong
    Wu, Yufeng
    He, Zhen
    Wang, Lili
    Zhang, Zhe
    Zhao, Dongdong
    Yang, Li
    Wei, Bing
    Ma, Jie
    Guo, Yongjun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S496 - S496
  • [47] CANCER STEM CELL-LIKE POPULATION FROM NON-SMALL CELL LUNG CANCER IS PREFERENTIALLY SUPPRESSED BY EGFR-TKIS
    Zhou, Qinghua
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S465 - S465
  • [48] ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer
    Dantong Sun
    Fei Teng
    Puyuan Xing
    Junling Li
    Molecular Medicine, 2021, 27
  • [49] PROTEOMIC SIGNATURE TO IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH EGFR-TKIS
    Lazzari, Chiara
    Gregorc, Vanesa
    Spreafico, Anna
    Vigano, Mariagrazia
    Milan, Enrico
    Bachi, Angela
    D'Amato, Alfonsina
    Sorlini, Cristina
    Roca, Elisa
    Villa, Eugenio
    ANNALS OF ONCOLOGY, 2009, 20
  • [50] Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer
    Hu, Wentao
    Liu, Yahui
    Chen, Jian
    ONCOTARGET, 2017, 8 (15) : 25046 - 25054
12345